Filtered By:
Vaccination: Measles Vaccine
This page shows you your search results in order of relevance. This is page number 18.
Order by Relevance | Date
Total 1238 results found since Jan 2013.
Acute Hemorrhagic Leukoencephalitis (AHLE): A Comprehensive Review on Causes, Symptoms, Link with COVID-19, Diagnosis, and Treatment
This study focuses on symptoms and causes of AHLE, difference between AHLE and ADME, diagnosis and treatment of AHLE, and its link with COVID-19.PMID:36425337 | PMC:PMC9681543 | DOI:10.1155/2022/6008375
Source: Biomed Res - November 25, 2022 Category: Research Authors: Mona Alromaihi Source Type: research
Detection of measles virus in Bulgaria from 2012 to 2018
CONCLUSION: Preventive measures are indispensable to limit the infection in different regions of Bulgaria and its spread to other countries. As vaccination coverage against measles and other vaccine-preventable infections, including SARS-Co2, is low, it is necessary to perform molecular identification of viruses to monitor their circulation and pathogenicity.PMID:36325672 | PMC:PMC9648082 | DOI:10.3325/cmj.2022.63.475
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Stefka Krumova Sabine Santibanez Ivona Andonova Radostina Stefanova Annette Mankertz Todor Kantardjiev Source Type: research
Progress Toward Measles and Rubella Elimination - India, 2005-2021
This report describes India's progress toward the elimination of measles and rubella during 2005-2021, with a focus on the years 2017-2021.¶ During 2005-2021, coverage with the first dose of a measles-containing vaccine (MCV) administered through routine immunization increased 31%, from 68% to 89%. During 2011-2021, coverage with a second MCV dose (MCV2) increased by 204%, from 27% to 82%. During 2017-2021, coverage with a first dose of RCV (RCV1) increased almost 14-fold, from 6% to 89%. More than 324 million children received a measles- and rubella-containing vaccine (MRCV) during measles-rubella SIAs completed in 34 (9...
Source: MMWR Morb Mortal Wkl... - December 15, 2022 Category: Epidemiology Authors: Ratnesh Murugan Kristin VanderEnde Veena Dhawan Pradeep Haldar Sourabh Chatterjee Deepa Sharma Kevisetuo Anthony Dzeyie Subramanya Balakuntlam Pattabhiramaiah Sudhir Khanal Lucky Sangal Sunil Bahl Sukarma S S Tanwar Michelle Morales Ahmed M Kassem Source Type: research
Detection of measles virus in Bulgaria from 2012 to 2018
CONCLUSION: Preventive measures are indispensable to limit the infection in different regions of Bulgaria and its spread to other countries. As vaccination coverage against measles and other vaccine-preventable infections, including SARS-Co2, is low, it is necessary to perform molecular identification of viruses to monitor their circulation and pathogenicity.PMID:36325672 | PMC:PMC9648082 | DOI:10.3325/cmj.2022.63.475
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Stefka Krumova Sabine Santibanez Ivona Andonova Radostina Stefanova Annette Mankertz Todor Kantardjiev Source Type: research
Progress Toward Measles and Rubella Elimination - India, 2005-2021
This report describes India's progress toward the elimination of measles and rubella during 2005-2021, with a focus on the years 2017-2021.¶ During 2005-2021, coverage with the first dose of a measles-containing vaccine (MCV) administered through routine immunization increased 31%, from 68% to 89%. During 2011-2021, coverage with a second MCV dose (MCV2) increased by 204%, from 27% to 82%. During 2017-2021, coverage with a first dose of RCV (RCV1) increased almost 14-fold, from 6% to 89%. More than 324 million children received a measles- and rubella-containing vaccine (MRCV) during measles-rubella SIAs completed in 34 (9...
Source: MMWR Morb Mortal Wkl... - December 15, 2022 Category: Epidemiology Authors: Ratnesh Murugan Kristin VanderEnde Veena Dhawan Pradeep Haldar Sourabh Chatterjee Deepa Sharma Kevisetuo Anthony Dzeyie Subramanya Balakuntlam Pattabhiramaiah Sudhir Khanal Lucky Sangal Sunil Bahl Sukarma S S Tanwar Michelle Morales Ahmed M Kassem Source Type: research
Detection of measles virus in Bulgaria from 2012 to 2018
CONCLUSION: Preventive measures are indispensable to limit the infection in different regions of Bulgaria and its spread to other countries. As vaccination coverage against measles and other vaccine-preventable infections, including SARS-Co2, is low, it is necessary to perform molecular identification of viruses to monitor their circulation and pathogenicity.PMID:36325672 | PMC:PMC9648082 | DOI:10.3325/cmj.2022.63.475
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Stefka Krumova Sabine Santibanez Ivona Andonova Radostina Stefanova Annette Mankertz Todor Kantardjiev Source Type: research
Progress Toward Measles and Rubella Elimination - India, 2005-2021
This report describes India's progress toward the elimination of measles and rubella during 2005-2021, with a focus on the years 2017-2021.¶ During 2005-2021, coverage with the first dose of a measles-containing vaccine (MCV) administered through routine immunization increased 31%, from 68% to 89%. During 2011-2021, coverage with a second MCV dose (MCV2) increased by 204%, from 27% to 82%. During 2017-2021, coverage with a first dose of RCV (RCV1) increased almost 14-fold, from 6% to 89%. More than 324 million children received a measles- and rubella-containing vaccine (MRCV) during measles-rubella SIAs completed in 34 (9...
Source: MMWR Morb Mortal Wkl... - December 15, 2022 Category: Epidemiology Authors: Ratnesh Murugan Kristin VanderEnde Veena Dhawan Pradeep Haldar Sourabh Chatterjee Deepa Sharma Kevisetuo Anthony Dzeyie Subramanya Balakuntlam Pattabhiramaiah Sudhir Khanal Lucky Sangal Sunil Bahl Sukarma S S Tanwar Michelle Morales Ahmed M Kassem Source Type: research
Detection of measles virus in Bulgaria from 2012 to 2018
CONCLUSION: Preventive measures are indispensable to limit the infection in different regions of Bulgaria and its spread to other countries. As vaccination coverage against measles and other vaccine-preventable infections, including SARS-Co2, is low, it is necessary to perform molecular identification of viruses to monitor their circulation and pathogenicity.PMID:36325672 | PMC:PMC9648082 | DOI:10.3325/cmj.2022.63.475
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Stefka Krumova Sabine Santibanez Ivona Andonova Radostina Stefanova Annette Mankertz Todor Kantardjiev Source Type: research
Progress Toward Measles and Rubella Elimination - India, 2005-2021
This report describes India's progress toward the elimination of measles and rubella during 2005-2021, with a focus on the years 2017-2021.¶ During 2005-2021, coverage with the first dose of a measles-containing vaccine (MCV) administered through routine immunization increased 31%, from 68% to 89%. During 2011-2021, coverage with a second MCV dose (MCV2) increased by 204%, from 27% to 82%. During 2017-2021, coverage with a first dose of RCV (RCV1) increased almost 14-fold, from 6% to 89%. More than 324 million children received a measles- and rubella-containing vaccine (MRCV) during measles-rubella SIAs completed in 34 (9...
Source: MMWR Morb Mortal Wkl... - December 15, 2022 Category: Epidemiology Authors: Ratnesh Murugan Kristin VanderEnde Veena Dhawan Pradeep Haldar Sourabh Chatterjee Deepa Sharma Kevisetuo Anthony Dzeyie Subramanya Balakuntlam Pattabhiramaiah Sudhir Khanal Lucky Sangal Sunil Bahl Sukarma S S Tanwar Michelle Morales Ahmed M Kassem Source Type: research
Detection of measles virus in Bulgaria from 2012 to 2018
CONCLUSION: Preventive measures are indispensable to limit the infection in different regions of Bulgaria and its spread to other countries. As vaccination coverage against measles and other vaccine-preventable infections, including SARS-Co2, is low, it is necessary to perform molecular identification of viruses to monitor their circulation and pathogenicity.PMID:36325672 | PMC:PMC9648082 | DOI:10.3325/cmj.2022.63.475
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Stefka Krumova Sabine Santibanez Ivona Andonova Radostina Stefanova Annette Mankertz Todor Kantardjiev Source Type: research
Progress Toward Measles and Rubella Elimination - India, 2005-2021
This report describes India's progress toward the elimination of measles and rubella during 2005-2021, with a focus on the years 2017-2021.¶ During 2005-2021, coverage with the first dose of a measles-containing vaccine (MCV) administered through routine immunization increased 31%, from 68% to 89%. During 2011-2021, coverage with a second MCV dose (MCV2) increased by 204%, from 27% to 82%. During 2017-2021, coverage with a first dose of RCV (RCV1) increased almost 14-fold, from 6% to 89%. More than 324 million children received a measles- and rubella-containing vaccine (MRCV) during measles-rubella SIAs completed in 34 (9...
Source: MMWR Morb Mortal Wkl... - December 15, 2022 Category: Epidemiology Authors: Ratnesh Murugan Kristin VanderEnde Veena Dhawan Pradeep Haldar Sourabh Chatterjee Deepa Sharma Kevisetuo Anthony Dzeyie Subramanya Balakuntlam Pattabhiramaiah Sudhir Khanal Lucky Sangal Sunil Bahl Sukarma S S Tanwar Michelle Morales Ahmed M Kassem Source Type: research
Detection of measles virus in Bulgaria from 2012 to 2018
CONCLUSION: Preventive measures are indispensable to limit the infection in different regions of Bulgaria and its spread to other countries. As vaccination coverage against measles and other vaccine-preventable infections, including SARS-Co2, is low, it is necessary to perform molecular identification of viruses to monitor their circulation and pathogenicity.PMID:36325672 | PMC:PMC9648082 | DOI:10.3325/cmj.2022.63.475
Source: Croatian Medical Journal - November 3, 2022 Category: General Medicine Authors: Stefka Krumova Sabine Santibanez Ivona Andonova Radostina Stefanova Annette Mankertz Todor Kantardjiev Source Type: research
